Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic and Clinical Value of Interleukin 6 and CD45+CD14+ Inflammatory Cells with PD-L1+/PD-L2+ Expression in Patients with Different Manifestation of Ovarian Cancer
Iwona Wertel, Dorota Suszczyk, Anna Pawłowska, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 14

Showing 14 citing articles:

Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer
Kaiyang Zhang, Erdoğan Pekcan Erkan, Sanaz Jamalzadeh, et al.
Science Advances (2022) Vol. 8, Iss. 8
Open Access | Times Cited: 117
Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes
Amin Ullah, Yongxiu Chen, Rajeev K. Singla, et al.
Pharmacological Research (2024) Vol. 204, pp. 107213-107213
Open Access | Times Cited: 12
H1.0 modulates IL-6 expression and paclitaxel resistance via HDAC5 in ovarian cancer cells
Shang‐Lang Huang, Ting‐Chang Chang, Nian‐Kang Sun
Biochemical Pharmacology (2025), pp. 116876-116876
Closed Access | Times Cited: 1
The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients
Izabela Szulc-Kiełbik, Michał Kiełbik, Marek Nowak, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188639-188639
Open Access | Times Cited: 34
Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis
Neda Dadgar, Christopher Sherry, Jenna Zimmerman, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Clinical and Prognostic Value of Antigen-Presenting Cells with PD-L1/PD-L2 Expression in Ovarian Cancer Patients
Anna Pawłowska, Agnieszka Kwiatkowska, Dorota Suszczyk, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11563-11563
Open Access | Times Cited: 25
Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis
Hina Amer, Apriliana E. R. Kartikasari, Magdalena Plebanski
Journal of Personalized Medicine (2021) Vol. 11, Iss. 12, pp. 1335-1335
Open Access | Times Cited: 22
The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer
Klaudia Parafiniuk, Wiktoria Skiba, Anna Pawłowska, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 920-920
Open Access | Times Cited: 13
Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy
Yogesh Godiyal, Drishti Maheshwari, Hiroaki Taniguchi, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Small secretory proteins of immune cells can modulate gynecological cancers
Niranjan Kumar, Akanksha Vyas, Saurabh Kumar Agnihotri, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 513-531
Closed Access | Times Cited: 10
Analysis of the Occurrence of Predicative Factors of Chronic Fatigue in Female Patients with Cancer of the Reproductive Organs with Respect to Stage of Treatment
Magdalena Kłysiak, Sylwia Wieder-Huszla, Dorota Branecka­‍-Woźniak, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3732-3732
Open Access | Times Cited: 5
Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis
Dorota Suszczyk, Wiktoria Skiba, Witold Zardzewiały, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11607-11607
Open Access | Times Cited: 8
Meta-analyses reveal serum or plasma Interleukin-6 as a biomarker for malignant ovarian neoplasia
Andrei Pașca, Eva Fischer‐Fodor, Nicoleta Monica Jiboc, et al.
Cytokine (2022) Vol. 161, pp. 156073-156073
Closed Access | Times Cited: 4
IL-6 as a predictor of survival rate in liver metastatic breast cancer patients with Covid-19 infection: A case series
Dea Alberta Setiawati, Widyanti Soewoto, Ikhdin Radiamin Saadhi
International Journal of Surgery Case Reports (2023) Vol. 107, pp. 108347-108347
Open Access | Times Cited: 1
Page 1

Scroll to top